Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Estetrol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mithra announces grant of two additional U.S. patents for NEXTSTELLIS®
    Mithra announces grant of two additional U.S. patents for NEXTSTELLIS®

    10 May 2024

    // PRESS RELEASE

    https://www.mithra.com/en/mithra-announces-grant-of-two-additional-u-s-patents-for-nextstellis/

    PRESS RELEASE
    10 May 2024
    Share Share
    First oral combined estetrol contraceptive available in UK
    First oral combined estetrol contraceptive available in UK

    20 Oct 2022

    // EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/175321/first-oral-combined-estetrol-contraceptive-available-in-uk/

    EUROPEANPHARMACEUTICALREVIEW
    20 Oct 2022
    Share Share
    Gedeon Richter announces availability of oral contraception Drovelis
    Gedeon Richter announces availability of oral contraception Drovelis

    20 Oct 2022

    // PHARMATIMES

    https://www.pharmatimes.com/news/gedeon_richter_announces_availability_of_oral_contraception_drovelis_1459350

    PHARMATIMES
    20 Oct 2022
    Share Share
    New Data Show NEXTSTELLIS Has Selective Impact On Endocrine Markers
    New Data Show NEXTSTELLIS Has Selective Impact On Endocrine Markers

    08 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/new-data-show-nextstellis-has-selective-impact-on-endocrine-markers-compared-with-common-combined-oral-contraceptives-301241886.html#:~:text=RALEIGH%2C%20N.C.%2C%20March%206%2C,including%20lower%20increases%20in%20hormone

    PRNEWSWIRE
    08 Mar 2021
    Share Share